Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
This company Fagi is very interesting I’ve been here since it was BHGI
I think Fagi is a very important company in the world right now because of the EBO2 patent that FAGI has.
Why is this important? Because of the vax. Simply put. It’s a way to clean the blood. The EBO2 machine never made it to market.
The EBO2 machine was sent to Trump administration just before the Covid outbreak. Shortly after I heard a Chinese general bought the majority of shares. But how? Were they sold on the open market?
This is a big deal and I believe the EB02 machine can help people but that’s not the goal around here.
What’s going on here guys?
This company Fagi is very interesting I’ve been here since it was BHGI
I think Fagi is a very important company in the world right now because of the EBO2 patent that FAGI has.
Why is this important? Because of the vax. Simply put. It’s a way to clean the blood. The EBO2 machine never made it to market.
The EBO2 machine was sent to Trump administration just before the Covid outbreak. Shortly after I heard a Chinese general bought the majority of shares. But how? Were they sold on the open market?
This is a big deal and I believe the EB02 machine can help people but that’s not the goal around here.
What’s going on here guys?
FAGI
Still looks like 💩 Poo Poo platter going nowhere since 2014. Insider self enrichment scheme. Eat my shares 🤮
THE LAST Q REPORT SHOWS THAT THEY LOST A TON OF MONEY.
Stock seems to finally be garnering some interest. Should easily be trading @ .13 +, on current revenue. It sure seems likes this new team is building something here. Bash away, but wasting your time. Gotta be in it to win is certainly the case here….
Clinic is open.
TAMPA, FL / ACCESSWIRE / July 9, 2024 / Full Alliance Group, Inc. (OTC Pink:FAGI) and DynaMAXX Health, Inc. are thrilled to announce the grand opening of the MAXX Health Clinic in The Villages July 11, 2024. This premier health clinic is set to revolutionize wellness and rejuvenation in the community and reward independent business owners who refer new clients. Join us for our Open House event on Thursday, July 11th, from 4 PM to 8 PM, to celebrate this momentous occasion.
TAMPA, FL / ACCESSWIRE / July 5, 2024 / Full Alliance Group, Inc. (OTC PINK:FAGI) is delighted to congratulate Corinne and Leslie, the visionary founders of Our Clean Paws., for their upcoming feature on Fox & Friends. The segment will air at 7:30 AM on Saturday, July 6, where they will be showcasing and discussing their innovative hypochlorous product for pets.
https://www.otcmarkets.com/stock/FAGI/news/Full-Alliance-Group-Inc-Congratulates-Corinne-Sanzone-and-Leslie-DuRant-of-Our-Clean-Paws-Inc-on-Their-Feature-on-Fox--F?id=445951
Full Alliance Group, Inc.’s (OTC:FAGI) Wholly Owned Subsidiary DynaMAXX Health, Inc. Launches PRiVIVE(TM) Topical Serum: A Revolutionary Solution for Cellular Rejuvenation and Dermal Health
Press Release | 06/18/2024
TAMPA, FL / ACCESSWIRE / June 18, 2024 / Full Alliance Group, Inc (OTC PINK:FAGI) is thrilled to announce the launch of PRiVIVE™ Topical Serum, a groundbreaking product designed to enhance cellular rejuvenation, collagen synthesis, dermal elasticity, and the relaxation of localized tissues. This unique and diverse formulation can be applied anywhere on the body, making it a versatile addition to anyone's skincare regimen.
Q1 out, A little more dilution and a little less revenue. We opened a clinic though.
https://www.otcmarkets.com/stock/FAGI/overview
"On March 29, 2024 four million (4,000,000) Class F Preferred Shares – Series F Preferred are being offered at $0.50 cents for a total potential offering of $2,000,000. (Management reserves the right to expand this offering.) Each Class F Preferred Share has antidilution consisting of the following: After a Thirty (30) for One (1) reverse split (“Split”) of the common shares each share of Series F Preferred will automatically convert into 10X the number of common shares. (Example: if the common stock is trading at .01 Cents prior to split, with all things being equal it will be trading at .30 cents after split each $1 invested in Series F Preferred will receive 20 shares of Common Shares after the Spilt.) As of March 31, 2024, the Company had raised $1,335,000 from eleven investors. "
and now back to 300,000,000.
FAGI Authorized Shares increased to 750,000,000 from 300,000,000.
checking in on FAGI
Since 2014 still looks like Poo Poo platter going nowhere. Insider enrichment scheme..... Eat my notes and shares
Yield Sign is back up.
https://www.otcmarkets.com/stock/FAGI/overview
LMAO.THE REVENUE FOR Q4 2023 WAS $ 551,000.00 FROM ZERO REVENUE IN 2022.Q4.
THE REVENUE FOR THE YEAR OF 2023 WAS $4,57 MILLION. FROM ZERO REVENUE IN 2022.
READ THE FILING DF.
https://www.otcmarkets.com/otcapi/company/financial-report/395863/content
2023 2022 2023 2022
Revenue $ 551,566 $ - $ 4,567,122 $ -
Why did Q4 revenue fizzle instead of sizzle?
IF YOU DO NOT OWN IT AND DO NOT LIKE IT.GO GET SOME OTHER STOCK YOU LIKE.VERY SIMPLE.
All of your cherry picked numbers are correct, but IMO don't tell a proper picture of the health or progress of FAGI. Investors should not ignore the facts that they have less than $2k in the bank after raising $1,374,775 in 2023 and their revenues dropped by 72.55% from Q3 2023 to Q4 2023 ( $2,009,651 Q3 vs $551,566 Q4 = negative 72.55%). Removing/discounting goodwill, investments in subs, increased inventory levels, increased accounts receivables should make you think twice about your total assets valuation. IMO, overall these are not the signs of a healthy company. P.S. I don't own shares in FAGI. Anxiously awaiting your all caps reply.
HUH????LOL.HIT LINK AND SCROLL DOWN TO SEE THESE NUMBERS BELOW TO VERIFY.
https://www.otcmarkets.com/otcapi/company/financial-report/395863/content
1)TOTAL ASSETS FOR 2023 $ 5,099,602 VS $ 1,825,604 IN 2022.
2)Total stockholder's equity FOR 2023 $ 2,635,496 VS 669,968=BOOK VALUE .024 PPS.
3)Revenue FOR THE Q4 2023 $ 551,566 $ VS ZERO REVENUE FOR Q4 2022
4)REVENUE FOR THE YEAR 2023 $ 4,567,122 VS REVENUE OF ZERO FOR 2022.
WTF ARE YOU TALKING ABOUT????
I don't know what financial statements you are looking at. All I see is Q4 revenue down 75% from previous quarter and only $2000 in the bank account. This does not appear to be going in the right direction.
FAGI SHOULD BE TRADING IN THE .16 PPS.OR $18 MILLION CAP.LIKE 4 TIMES THE YEARLY REVENUES.
THE YEAR REPORT AND Q4 IS FILED.TREMENDOUS.BOOK VALUE .024.PPS.
1)TOTAL ASSETS $ 5,099,602 FROM $ 1,825,604=ASSETS UP OVER $3 MILLION.
2)Total stockholder's equity $2,635,496 FROM $669,968=SHAREHOLDER EQUITY UP $2 MILLION.
3)BOOK VALUE =.024.AND THE PPS IS .01?????LOL.
4)Revenue FOR Q4 $ 551,566 $ AND YEARLY REVENUES $ 4,567,122
His achievements are a testament to his leadership and vision, having been named Top Sales Person in the US for Carnation Foods which rewarded Craig for a scholarship at Florida State University, and later, won Entrepreneur of the Year for starting an apparel company as well as pioneering a campus map for new students at no cost by creating a coop advertising model during his MBA studies at the University of South Florida. Craig's tenure as a top commercial banker, managing a portfolio in excess of $100,000,000 and securing the largest loan in the bank's history for an iconic sports team, underscores his financial acumen. Craig was a correspondent with Greystone for multi-family and sub-prime commercial loans.
https://www.otcmarkets.com/stock/FAGI/news/Full-Alliance-Group-Inc-Announces-Craig-Lane-as-President-of-its-wholly-owned-subsidiary-DYNAMAXX-Health-Inc-OTC-FAGI?id=433226
Full Alliance Group, Inc. Announces Craig Lane as President of its wholly owned subsidiary DYNAMAXX Health, Inc. (OTC: FAGI)
Press Release | 03/13/2024
TAMPA, FL / ACCESSWIRE / March 13, 2024 / Full Alliance Group, Inc. (OTC PINK:FAGI) is excited to announce the appointment of Craig Lane as President of Dynamaxx Health, Inc., a subsidiary dedicated to pioneering advancements in cash pay anti-aging and rejuvenation healthcare. With an extensive background in healthcare management and finance, Craig is perfectly positioned to lead Dynamaxx Health into a future with innovation and growth.
Craig brings to the table an impressive repertoire of expertise in healthcare management, sales, and corporate leadership. His career highlights include over a decade of impactful roles at Valet Orthopedics and SurgCap Funding, where he excelled in managing clinics, optimizing revenue cycle management, building clinics, developing financial structures conducive to growth and efficiency, and successfully exiting his own clinics.
His achievements are a testament to his leadership and vision, having been named Top Sales Person in the US for Carnation Foods which rewarded Craig for a scholarship at Florida State University, and later, won Entrepreneur of the Year for starting an apparel company as well as pioneering a campus map for new students at no cost by creating a coop advertising model during his MBA studies at the University of South Florida. Craig's tenure as a top commercial banker, managing a portfolio in excess of $100,000,000 and securing the largest loan in the bank's history for an iconic sports team, underscores his financial acumen. Craig was a correspondent with Greystone for multi-family and sub-prime commercial loans.
Bill Heneghan, COO of Full Alliance Group, commented on Craig's appointment, "Craig's in-depth knowledge and experience in healthcare management set him apart as the ideal leader for Dynamaxx Health. His proven track record in enhancing clinic operations and financial strategies aligns perfectly with our vision for MAXX Health Clinics. We are confident that Craig's leadership will propel Dynamaxx Health to forefront positions in healthcare innovation."
As President of DYNAMAXX Health, Craig's robust background in marketing, finance, and particularly healthcare, will guide the organization toward achieving its goals for expansion and innovation. His capability to manage complex business operations and drive rapid scaling initiatives is crucial for Dynamaxx Health's ambition to become a leading name in providing cash pay medical services through its MAXX Health anti-aging and rejuvenation clinics.
About Full Alliance Group, Inc.
Full Alliance Group, Inc. is a holding company in the health and wellness sector.
FAGI's wholly owned subsidiary, Bio Lab Naturals, Inc., founded in 2000, through its FDA-registered wholly owned subsidiary Pure Solutions, Inc., was built on the simple principles of using the highest quality ingredients, producing products with the greatest possible efficacy, and providing its partners with unsurpassed customer service all at a fair price. From day one, the Company has specialized in custom product development and FDA-compliant contract manufacturing, with a passion for cutting-edge formulations and innovative product selection. Now housed in a state-of-the-art 25,000 square foot facility in Tampa, Pure Solutions remains committed to its founding principles and is ready to expand its operations through growing organically by adding diversity to its in-house product lines and strategically through joint ventures, partnerships, acquisitions, exclusive manufacturing and distribution agreements, and mergers.
FAGI's other wholly owned subsidiary DYNAMAXX International Ltd. is in the health and supplement space using the direct selling channel as its sales force with its main operations in the United States and Canada. DYNAMAXX was founded in 2009 and has expanded globally since that time with its line of supplements. In addition to having a world class supplement product line, in October 2023 DYNAMAXX launched the first ever cash pay medical referral network through its independent reps ("Members"); allowing its Members to refer friends, family, other Members and customers to doctors who participate in the Dynamaxx Health Network. Initially, Dynamaxx Health Inc. is referring patients for EBOO/EBO2, PRP, Shockwave procedures to Doctors in the network. DYNAMAXX has a cost-effective way for individuals to participate in the ever-growing GIG economy by offering an aggressive compensation program to those that refer customers who purchase products, refer individuals to the Dynamaxx Health Network or to other individuals who want to start their own business. The company offers training and support to their distributors and has a strong focus on helping people achieve financial freedom through their business opportunity.
I CAN NOT POST CUT AND PASTE FROM SCHWAB.BUT IT IS VERY GOOD NEWS.
What's the news?
FAGI HAS BIG NEWS OUT. TODAY.
The last annual was published 2/21/23.
END OF MARCH THE YEARLY REPORT DUE.
Guess it’s the 10k next, not sure when it’s due, but it should be good!
Must be earnings day with this volume.
Spifster, did this get released after 4pm et today? I think it did, but no time printed on pr.
FAGI.0084.TREMENDOUS NEWS OUT.OTC DISCLOSURE & NEWS SERVICE
Millionaires Club Founder and Top 100 Global MLM Earner Edgar Mojica Joins DYNAMAXX as Co-Founder: Full Alliance Group (OTC: "FAGI") Teams Up with Network Marketing Dynamo, Edgar Mojica, who will be Leading DYNAMAXX in its International Expansion, Product
Press Release | 01/31/2024
TAMPA, FL / ACCESSWIRE / January 31, 2024 / Full Alliance Group, Inc. (OTC Pink:FAGI) is thrilled to announce the addition of Edgar Mojica as Co-Founder of DYNAMAXX International LTD's relaunch. With an illustrious 30-year career in the dynamic world of network marketing, Mojica's extensive experience spans decades, earning him the prestigious title of a Top 100 global income earner.
Edgar Mojica is a bilingual professional, fluent in both Spanish and English, whose success extends across diverse markets. With a remarkable track record as a multi-million dollar earner and producer, Mojica has cultivated a network of over 1.2 million team associates, customers, and affiliates spanning across 128 countries. He is the Founder and President of the Millionaires Club, a testament to his exceptional leadership and success in the industry. #EdgarMojicaNetwork
Stepping into the role of DYNAMAXX Corporate and Field Leadership Development Team member, Edgar Mojica is positioned to be a key player in propelling the growth and triumphs. His extensive 30 years of experience, strategic foresight, and dynamic leadership style seamlessly align with the core goals and values of Full Alliance Group, Inc.
Jay Archer, CEO of DYNAMAXX, expressed excitement about Mojica's inclusion, stating, "We are thrilled to welcome Edgar Mojica as Co-Founder of DYNAMAXX. His extensive 30 years of experience, leadership, and global success in network marketing will undoubtedly contribute significantly to the continued growth and success of DYNAMAXX."
For Full Alliance Group, Inc., aligning with Edgar Mojica represents a strategic maneuver to reinforce its foothold in the thriving health and nutraceutical sector. Mojica's track record in building and steering high-performance teams, coupled with his expansive global network, is poised to unlock fresh avenues for expansion. The partnership gains added significance with insights from the Global Wellness Institute, highlighting wellness as a burgeoning global market with $5.6 trillion in revenue in 2022. This amalgamated entity is strategically positioned to seize opportunities within this lucrative industry, harnessing Mojica's expertise to propel innovation in the realm of health and wellness.
Bill Heneghan, COO of Full Alliance Group, Inc., echoed the sentiment, stating, "Edgar Mojica's addition to our leadership team is a tremendous asset. His remarkable 30 years of experience, achievements, and leadership qualities align perfectly with our vision for strategic growth, and we are excited about the future opportunities Edgar brings."
The merger of Full Alliance Group, Inc., and DYNAMAXX International LTD, now enhanced by the inclusion of Edgar Mojica, positions the company for sustained success and innovation in the health and wellness sector. This collaboration promises to be a driving force behind the company's journey towards greater achievements in the future.
The market recognizes FAGI for what it has been since its inception.... Poo Poo platter going nowhere.
FAGI.008.Total stockholder's equity WENT TO $2,387,105 FROM $669,968=BOOK VALUE NOW IS .021.AND THE STOCK IS .008????LOL.MAKES NO SENSE.THIS IS NOT LONGER A SHELL.IT TRADED MUCH HIGHER WHEN IT WAS A SHELL.
Revenue FOR Q3 $ 2,009,651 $ VS ZERO A YEAR AGO Q3. 9 MONTHS REVENUES $ 4,015,556 $ VS ZERO A YEAR AGO 9 MONTHS.IF WE TRADE AT 4X REVENUES=CAP OF $16 MILLION OR .144 PPS.WE ARE AT .008????LOL.
Q3 finally out. $4M in sales for 9-months ended 9/30/23
https://www.otcmarkets.com/otcapi/company/financial-report/389161/content
I AM NOT WORRIED TO LOSE.THEY HAVE TO LOSE 1000 TIMES MORE THAN ME.IT SHOULD BE FUN.IN THE MEAN TIME.
Wish you and everyone best of luck here. Always believed FAGI was Poo Poo platter looking for victims unfortunately... Nothing here but smoke and mirrors going nowhere.
THEY ARE GOING TO LEARN THE HARD WAY.WHEN F IN AROUND WITH PROS.GAMES MF INSIDERS DO NOT WORK FOR ME.I AM NOT HERE TO PLAY YOUR STUPID GAMES.I WILL RIP YOUR STUPID A$$ES.KEEP ON GOING WITH YOUR SKEAKY STUPIDITY.TO SHAKE ME OUT BY NOT FILING.LMAOOOOOOOO.I SEND 4 COMPANIES IN THE EXPERT MARKET.AND THEY ARE GOING TO BE THER FOR MANY YEARS.I DO NOT HAVE TO TAKE A LOSS.I WILL RIDE THEM TO ZERO.ITS ON MY IRA ACCOUNT.NO WORRIES.BUT IF THEY DARE TO FILE AND COME BACK IN THE PINK MARKET I WILL GET EVEN IN THE WORST WAY.THEN IS WHEN THEY WILL REALIZE WHY IN THE F PUNISHING OUR OWNSELVES???BECAUSE YOU ARE FREAKEN IDIOTS.THIS IS WHY,
MAYBE FAGI WILL BE THE NEXT ONE TO ENTER THE EXPERT MARKET.THAT WILL BE GREAT.ALL THE MERGERS AND ALL FOR NOTHING.STUPID IDIOTS.LMAOOOOOOOOOO
FAGI Poo Poo platter.... Good luck everybody ! You have been bent over and Fagied ... Triple Zeros incoming Ouch lol
FAGI IS HEADED TO EXPERT MARKET.IT TURNED THE LIGHTS OUT.THE END IS NEAR.
FAGI ...... After almost a decade FAGI is still just sub penny Poo Poo platter doing nothing and going nowhere. Good luck everybody
VERY BAD NEWS BRO.THEY DECIDED TO GO DARK.NO FILING.PAST DUE.AND WE GOT THE LIMITED SIGN ON=WE ARE GOING TO EXPERT MARKET SOON,AND YOU WILL NOT BE ABLE TO TRADE IT.FOR THAT ORCA WE TAKE THEM BANKO.I DO NOT F AROUND
THEY HAVE BEEN PUNISHING SHAREHOLDER FOR WAY TO LONG.TIME TO TAKE OUT OF BUSINESS.THE END IS NEAR.
https://www.otcmarkets.com/stock/FAGI/disclosure
Pink Limited Information
WAITING FOR IT.I WILL POST A REPORT OF MINE AFTER I READ IT.
Followers
|
137
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
26150
|
Created
|
01/03/11
|
Type
|
Free
|
Moderators |
FAGI SECURITY DETAILS
Share Structure:
Authorized: 500M
Outstanding: 55,843,301 (as of Jan 30 2019)
Restricted 27,006,442
Free trading/Float: 28,836,859.
PALM DESERT, CA / ACCESSWIRE / March 6, 2019 / Full Alliance Group, Inc. (OTC PINK: FAGI) ("Full Alliance Group" or the "Company"), is pleased to announce the appointment of Rick A. Low, MD, FACS, to its Medical Advisory Board.
Born in Honolulu, Hawaii, Dr. Low is a Fellow of the American College of Surgeons with over 25 years experience. Following his 1994 graduation from Johns Hopkins University School of Medicine in Baltimore, Maryland, Dr. Low interned at Cedar-Sinai Medical Center in Los Angeles, California, where became a resident surgeon and eventually Chief Surgical Resident. From 1999 to 2017, he practiced at Valley Surgical Clinics in Phoenix, Arizona. He is currently practicing still in the Phoenix area at Desert Surgical Specialists, a general surgery practice with a focus on general, laparoscopic, and robotic surgery.
Dr. Low is affiliated with Honor Health, North Mountain campus (1999 - current) where he is Chairman, Network Robotic Surgery (2013-current) and Surgeon Champion NSQIP (2016 - current), Honor Health, Deer Valley campus (2008 - current) where he was Chairman, Department of Surgery (2011 - 2016), Paradise Valley Hospital (1999 - current) where he was Chairman, Department of Surgery (2008-2009), Honor Health, Thompson Peak campus (2007 - current), and Honor Health, Shea campus (1999 - current).
Dr. Low has also a highly regarded instructor and guest speaker having trained hundreds of surgeons nationwide in laparoscopic and robotic surgeries including cholecystectomy, colon resection, and hernia repair, and lectured at numerous professional events and conferences. Dr. Low's research has been published in The Annals of Thoracic Surgery, Head & Neck, and Journal of Robotic Surgery.
Dr. Paul Brian Volpp, CEO and President of Full Alliance Group, commented, "We are excited to have Dr. Low join our Medical Advisory Board along with current members Drs. Durrani, Collins, and Purita. Their combined expertise should provide us with an immediate competitive advantage and help to establish Full Alliance Group and its subsidiaries as leading providers in healthcare and medical services."
Sincerely,
Dr. Paul Brian Volpp
President & CEO / Director
Full Alliance Group Inc.
LOS ANGELES, Feb. 28, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Full Alliance Group, Inc. (OTCPK: FAGI) ("Full Alliance Group" or the "Company"), is pleased to announce the formation of its Medical Advisory Board.
Dr. Paul Brian Volpp, CEO and President of Full Alliance Group, commented, "We expect the next several months to be extremely exciting and productive for Full Alliance Group as we move to rapidly accelerate our operations in the healthcare and medical sectors. The formation of a Medical Advisory Board will provide us with access to additional experienced professionals and proven leaders that can offer invaluable guidance to the Company and its subsidiaries as we continue to execute our business plans."
First to join Full Alliance Group's Advisory Board are three American medical professionals; Dr. Samedyar (Sam) Durrani, Dr. Catherine Collins, and Dr. Joseph R. Purita.
Samedyar (Sam) Durrani, MD, born and raised in the Midwest, is a proud graduate of The Ohio State University and The University of Cincinnati College of Medicine. He completed his residency training in general surgery at Mount Carmel Medical Center in Columbus, Ohio. Currently based in the Phoenix, Arizona area since 2010, he established Desert Surgical Specialists, a general surgery practice with a special focus in pancreatic surgery, endocrine surgery, oncologic surgery, and advanced techniques in hernia repair. Dr. Durrani also provides trauma surgery coverage for various hospitals in his area. Dr. Durrani has hospital privileges at Scottsdale Osborn Medical Center, Scottsdale Shea Medical Center, Scottsdale Thompson Peak Medical Center, Deer Valley Medical Center, and John C Lincoln Medical Center. He is certified by the American Board of Surgery.
Christine Collins, MD, is board certified by the American Board of Obstetrics and Gynecology and is a member of the American College of Obstetrics and Gynecology. A graduate of the USC School of Medicine, Beverly Hills gynecologist Christine Collins has been an attending physician at Cedars-Sinai Medical Center for over 20 years, where she also completed her residency training. Dr. Collins was awarded the prestigious ARCS scholarship while in medical school and also merited status as a Dean's Scholar upon graduation. Though she is a traditional GYN, she values the holistic side of medicine and proudly offers this underappreciated route of treatment to the valued patients of her private practice. Dr. Collins is also board certified in anti-aging and regenerative medicine.
Joseph Purita, MD, a regenerative medicine pioneer in the use of stem cell and PRP therapy for orthopedic conditions, graduated from Georgetown University Medical School and served his surgical internship at the University of Florida Medical Center. Following completion of his orthopedic surgery residency at University of Miami-Jackson Memorial Hospital, where he served as the Chief Administrative Resident, Dr. Purita joined the Boca Raton Orthopedic Group in 1981. Dr. Purita is a founding member of the American Academy of Regenerative Medicine and is certified by several organizations, including the American Board of Orthopedic Surgery, American College of Orthopaedic Surgery, American Board of Pain Management, and American Board of Regenerative Medicine. In 2014, Dr. Purita was named one of U.S. News & World Report's "Top Doctors" by the physicians at Doximity, a U.S. healthcare professional network with over 1 million members.
Dr. Volpp concluded, "We are honored to have Drs. Durrani, Collins, and Purita as the first members of the Full Alliance Group Medical Advisory Board. Their extensive knowledge of medicine, patient care, and healthcare business operations will be a great benefit to the Company and its shareholders going forward."
Full Alliance Group anticipates appointing additional members to the Medical Advisory Board over the next several weeks which should further enhance management's ability to direct the future growth of the Company.
Sincerely,LOS ANGELES, Feb. 26, 2019 (GLOBE NEWSWIRE) -- via OTC PR WIRE -- Full Alliance Group, Inc. (OTCPK: FAGI) ("Full Alliance Group" or the "Company"), is pleased to announce that Dr. Paul Brian Volpp has succeeded Jacob Thomas as CEO and President of Full Alliance Group upon Thomas's retirement. In addition, Mr. Rudy Kiste, currently the Company's Chief Financial Officer, will join the Full Alliance Group board of directors.
"We would like to sincerely thank Jacob Thomas for his years of leadership and service to Full Alliance Group as CEO, President, and Chairman of the Board. We wish him the best in retirement," stated newly appointed CEO and President, Dr. Paul Brian Volpp. "In taking the helm at Full Alliance Group, I am confident that my medical education, training, and hands-on experience at providing patient care in my own practice and in large hospital settings will enable me to lead the Company's expansion in healthcare and nutraceuticals."
P. Brian Volpp, M.D., MPH completed undergraduate work at Princeton University where he graduated cum laude with a degree in history and a certificate in American Studies. He subsequently completed a dual M.D./MPH program, studying medicine in his adopted home state of Nevada and public health administration at Loma Linda University, where he was selected to the Delta Omega Honor Society.
He completed his residency in Los Angeles, first in preliminary medicine at Cedars-Sinai Medical Center followed by radiation oncology training at Kaiser Permanente. Dr. Volpp is board certified in both radiation oncology and integrative medicine, and practices at Palomar Hospital in Escondido as well as all three Sharp hospitals in greater San Diego. He is currently medical director of radiation therapy at Palomar as well as medical director for San Diego Radiosurgery.
During his career, Dr. Volpp published peer-reviewed research on spinal cord tumors and prostate cancer. Special interests include radiosurgery, integrative and complementary cancer medicine as well as palliative care/pain management.
Dr. Volpp concluded, "Over the next several weeks, we anticipate adding several additional senior team members and advisors to the Full Alliance Group team. I look forward to working with our growing teams to execute our refocused business strategy."
LOS ANGELES, CA / ACCESSWIRE / February 19, 2019 / Full Alliance Group, Inc. (OTC PINK: FAGI) (''Full Alliance Group'' or the ''Company''), today announced it has entered into a definitive Stock Acquisition Agreement with Dr. Louie Yu, sole shareholder of proprietary nutraceutical developer Nutra Yu, Inc. (''Nutra Yu'') and innovative blood therapy company EBO2, Inc. (''EBO2''), pursuant to which both Nutra Yu and EBO2 have become wholly-owned subsidiaries of Full Alliance Group.
Pursuant to the Stock Acquisition Agreement, Full Alliance Group acquired all the outstanding shares of both Nutra Yu and EBO2 in exchange for the issuance of 5,000,000 ''restricted'' shares of FAGI common stock and 25,000,000 shares of Series B Preferred Stock.
In connection with the closing of the acquisitions, Dr. Louie Yu was appointed Chief Medical Officer of Full Alliance Group. With nearly 25 years of specialized education, training, and patient practice, Dr. Yu is an international medical consultant, Doctor of Traditional Chinese Medicine (TCM) and Doctor of Chiropractic specializing in orthomolecular medicine. Dr. Yu is considered a pioneer in oxidative medicine, which is still in its infancy. He was the protégé of the late Dr. Alfred Libby, one of the fathers of Orthomolecular medicine, homeopathy, and nutraceutical formulation. In 2012 Dr. Yu's multi systems approach to medicine were proven via a clinical trial conducted at the World Clinical Trials Center, which was a collaboration between Dr. Yu's Methods and the Biologique center for Regenerative Medicine. Known worldwide as the creator of Quantum Energetic Medicine, he has been able to bridge the gap between modern medicine, and the curative wisdom of the East. Additional management changes and additions are expected in the near future that will further establish the Company within the nutraceutical and healthcare sector.
Dr. Paul Brian Volpp, Director of Full Alliance Group, commented, ''We are very pleased to have successfully launched Full Alliance into the rapidly expanding medical healthcare and nutraceutical industries with the acquisition of Nutra Yu and EBO2. Under the guidance of their founder, renowned doctor and nutraceutical and alternative medicine expert, Dr. Louie Yu, with his long list of proprietary formulations nutritional therapy protocols, we plan to quickly and strategically expand Nutra Yu and EBO2 brands, services, and locations with new distribution channels in markets around the globe. We look forward to assisting Dr. Yu and his team to build Nutra Yu and EBO2 into globally recognized and trusted names in healthcare and nutraceuticals.''
Dr. Louie Yu, Chief Medical Officer of Full Alliance Group and founder of Nutra Yu and EBO2, commented, ''These two companies have access to the entirety of training, knowledge, and research that I have conducted over my lifetime and career in search of effective cutting-edge medicines, remedies, and regenerative treatments. Over the next few months, we plan to dramatically ramp up distribution and marketing for our Nutra Yu product line, direct new clinical studies, and potentially open the first EBO2 clinics in several states in the U.S. With new regulations and legal protections recently enacted in many U.S. states, we are confident that we are entering a very exciting period of growth, expansion, and acceptance for complementary and alternative medicine in America. Nutra Yu, EBO2, and Full Alliance Group are well-positioned to take full advantage of this growing long-term trend.''
Sincerely,
Jacob Thomas
CEO, Chairman of the Board
About Nutra Yu, Inc.
Nutra Yu, Inc. was founded by Dr. Yu to further develop, market, and distribute his proprietary line of nutraceuticals. Nutra Yu's ''Dr. Louie Yu Formulations'' are a complete product line of unique all-natural nutraceuticals based on the science of traditional Chinese medicine, Western orthomolecular concepts, and modern-day physics. This innovative fusion of eastern and western methodologies has generated a remarkable new scientific system which management believes effectively addresses the root of most daily health conditions - inflammation, weight gain, the loss of vital energy, and environmental toxicity.
The Dr. Louie Yu Formulations brand currently consists of more than ten (10) distinct products, including multivitamins and minerals, amino acid blends, immune boosters, digestion aids, sleep aids, stress relief, and hormone support. Dr. Yu's orthomolecular formulation of ingredients are not found in any other supplement product and contain no starch, corn, milk, wheat, yeast, sugar, caffeine, eggs, salt, artificial colors, binders, flavors, preservative or fish derivatives. Dr. Louie Yu Formulations are sold direct to consumers via various Dr. Yu clinics/practices and recently online through Amazon.com.
For additional information regarding Nutra Yu, visit www.drlouieyu.com
About EBO2, Inc.
EBO2, Inc. is the provider of ''EBO2'', a second-generation blood treatment technology developed by Dr. Yu over the past 20 years which management believes is 100x faster and more efficient than traditional outdated autohemotherapy and 10 pass techniques. Combined with exclusive pre- and post-treatment nutraceuticals developed exclusively by Dr. Yu, the EBO2 procedure is the world's most advanced medical ozone treatment performed today.
The EBO2 procedure is a minimally invasive intravenous therapy similar to hemodialysis developed as a treatment for many cardiological problems, allowing the patient to avoid life threatening, highly risky, painful, expensive and complicated surgeries and long recovery periods. In this procedure, EBO2 re-circulates all a patient's blood (5-7 liters) over a period of 60-90 minutes for treatment with medical ozone to remove extra inactive proteins which lead to autoimmune related disorders, separate fats, cholesterol, heavy metal toxins, and diseased dead cells and then traps and removes impurities and fats in special patented filtration system.
Medical ozone therapy is already a well-established alternative and complementary therapy in most major European countries, including Germany, France, Italy, Austria and Switzerland. Other countries are also active in ozone therapy, including Russia, Greece, Israel, Japan, Malaysia, Mexico, Brazil, Columbia, Argentina, Dominion Republic and Cuba. In the United States, Complementary and Alternative Medicine (CAM) legislation has now made medical ozone therapy an option for some patients in thirteen states, including Alaska, Arizona, Colorado, Connecticut, Georgia, Minnesota, Nevada, New Mexico, New York, Ohio, Oregon and Washington. EBO2 intends to provide treatments in the United States from company owned and operated clinics in CAM friendly states.
For additional information regarding EBO2, visit www.fullalliance.com
Full Alliance Group management and board of directors anticipate making decisive assessments regarding the direction of the previously announced fintech acquisitions of MY PAY, Kelevra Digital Solutions, and GBE Grupo Empresarial de Tamaulipas SAPI. Additionally, Full Alliance Group would like to announce the termination of the previously announced Purchase Agreement to acquire a New York-based investment banking firm as the selling parties requested the unacceptable removal of a previously agreed upon binding ''No Share Consolidation'' clause required to protect the interests of current shareholders.
Contact: ir@fullalliance.com
Passage- More Info
Soma Plex- More Info
Balance- More Info
CEE Minerals- More Info
Endocrine Plus- More Info
In treating almost every type of disease known to man, there has been one constant, nutritional therapy and diet has always played a key role to disease and dysfunction. This is a key difference to my understanding of treatment and formulations which differs from the vast majority.
The last few years have been dedicated to chiropractic, orthomolecular medicine and EBOO ozone technologies. What is interesting is that all the assumptions made about the health status of the human body through advanced diagnostic testing is that of the blood, is that blood observed in the EBOO protocols much different than previously known. EBOO stands for Extracorporeal Blood Oxygenation and Ozination. EBOO is the worlds most advanced and critical medical ozone treatment performed today. With my development with EBOO we can see that the fats that are the leading cause of cardiovascular disease occurs much earlier than previously predicted or known, which increase the risk factors for cardiovascular events such as heart attacks, transient ischemic attacks and strokes by almost 200%
Based on my research and understanding the new line of nutraceuticals are all formulated with the understanding that the blood and the body are reacting much different than what is known today. This premise is based on the fact that we see more fats and toxins in the blood while performing the EBOO protocols. To take a healthy male or female with a good medical history, good diet history, and good nutritional supplement program and see that when performing the EBOO procedure, that the blood is laden with fats, plaques, heavy metals, and toxins.
You take sick people with specific diseases and make them well; you take healthy people and make them better all the while seeing drastic changes in their appearances. This is the newest form of anti-aging medicine and the best treatment of most heart conditions eliminating the need for surgery. This all done by EBOO technologies.
The nutraceuticals that I formulate, manufacture and distribute are unique in the market place. They are formulated with three things in mind.
Delivery system. The products are designed to pass into the blood stream using different mechanisms of delivery in the body. Most nutritional products do not take into consideration the disease state of the patient. The ability to assimilate the products and what happens to the products as they enter the system. How does the product go through gastrointestinal assimilation and what are the pitfalls to normal digestion and metabolism of the pills, capsules, tablets and liquids. As well as how they are in turn used by the system. Each product has a unique site of metabolism if attached to a specific delivery system. Delivery is paramount when you talk about nutrition and supplements. If you are only counting on the fact that you put a pill into your mouth or drink a magic potion to heal yourself then you are sadly mistaken. You must have a delivery system in place to insure your body will maximize absorption and utilization of the products.
Stability. How are the products stabilized? What mechanism are used to ensure product stability not only in the product form but as well how they remain stable in the body after consumption and utilization. I am concerned with the different types of preservatives and chemical stabilizers that keep the product intact for their intended use, keeping to more natural forms that mimic what occurs in nature. Fat content, solubility, temperature in various organs etc.
Synergy. I have developed what I call synergistic strategies for formulation. I check not only the chemical compatibility of the ingredients but the energetic compatibility as well. This is a unique and proprietary process only known to me. That thought process and energetic testing are solely an invention to me and no one else in the world.
Clinical observation. Products are used on my patients in my office based on their specific disease state. With that in mind, when products are in the beta phase of testing, I have patients with specific problems in physiology and try them to see if they are effacious. The idea being if these patients can absorb, metabolize and utilize the products well, then the average person in reasonable health will do so much more efficiently. This is the reason why my nutritional supplements and EBOO protocols are called “First Choice for a Second Chance.” Most of my patients have been through the gambit of doctors and treatments and have been failed medically or by alternative complimentary therapies. They come to me out of hope and desperation to find a way to better health.
Because I take these factors into account, the products are unique to my clinical practice. All formulations are made out of necessity for the patient’s health benefit. As I work as an active clinician, I see trends in health and disease, therefore I stay ahead of the game by introducing products based on treatment needs since food and nutrition are the keys to maintaining good health and well-being.
Dr. Louie Yu
EBO2, Inc. is the provider of “EBO2”, a second-generation blood treatment technology developed by Dr. Yu over the past 20 years which is 100x faster and more efficient than traditional outdated autohemotherapy and 10 pass techniques. Combined with exclusive pre- and post-treatment nutraceuticals developed exclusively by Dr. Yu, the EBO2 procedure is the world’s most advanced medical ozone treatment performed today.
The EBO2 procedure is a minimally invasive intravenous therapy similar to hemodialysis developed as a treatment for many cardiological problems, allowing the patient to avoid life threatening, highly risky, painful, expensive and complicated surgeries and long recovery periods. In this procedure, EBO2 re-circulates all a patient’s blood (5-7 liters) over a period of 60-90 minutes for treatment with medical ozone to remove extra inactive proteins which lead to autoimmune related disorders, separate fats, cholesterol, heavy metal toxins, and diseased dead cells and then traps and removes impurities and fats in special patented filtration system. EBO2 also helps with reversing auto immune related diseases, inflammatory diseases and arthritis, as well as Lyme disease and it’s related co-infections.
Medical ozone therapy is already a well-established alternative and complementary therapy in most major European countries, including Germany, France, Italy, Austria and Switzerland. Other countries are also active in ozone therapy, including Russia, Greece, Israel, Japan, Malaysia, Mexico, Brazil, Columbia, Argentina, Dominion Republic and Cuba. In the United States, Complementary and Alternative Medicine (CAM) legislation has now made medical ozone therapy an option for some patients in thirteen states, including Alaska, Arizona, Colorado, Connecticut, Georgia, Minnesota, Nevada, New Mexico, New York, Ohio, Oregon and Washington. EBO2 intends to provide treatments in the United States from company owned and operated clinics in CAM friendly states.
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |